Paper Details

  1. Home
  2. Paper Details

Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study.

Author: , GálvezM C, LozanoF, LópezM, López-CortésL F, PalaciosR, RiveroA, RíosM J, SantosJ, Torres-TortosaM, de la TorreJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

The once-daily combination of didanosine-lamivudine-efavirenz resulted in sustained viral suppression and was well-accepted by patients. Associated adverse events and virological failures were few.
Paper Details　
Original Abstract of the Article :
PURPOSE: Our aim was to analyze the efficacy and safety of didanosine-lamivudine-efavirenz in a cohort of HIV patients starting antiretroviral therapy between January and September 2003. METHOD: We undertook a prospective, open-label, observational, multicenter study. RESULTS: 163 patients were en...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1310/1XAE-BB0W-QN5R-AJGJ

データ提供：米国国立医学図書館（NLM）

A Simple and Effective Once-Daily Antiretroviral Regimen for HIV Patients

The field of [HIV/AIDS treatment] is constantly evolving, aiming to [improve the efficacy and simplify the regimens] of [antiretroviral therapy]. This research evaluates the [efficacy and safety] of a [once-daily antiretroviral regimen] consisting of [didanosine, lamivudine, and efavirenz] in [HIV-positive patients]. The authors conducted a [prospective, observational study] to assess the [clinical outcomes] of this regimen in a [cohort of naive patients]. Their findings suggest that the [once-daily regimen] resulted in [sustained viral suppression] and was [well-tolerated] by patients, offering a [convenient and effective treatment option] for [newly diagnosed HIV patients].

Improving Adherence and Simplifying Treatment

This study underscores the importance of [simplifying antiretroviral regimens] to [improve patient adherence and overall treatment outcomes]. The [once-daily regimen] offers a [more convenient and manageable] approach to [HIV treatment], potentially leading to [better viral control] and [improved quality of life] for patients.

Navigating HIV Treatment: A Collaborative Approach

The management of [HIV infection] requires a [collaborative approach] between [patients and healthcare providers]. [Regular monitoring] and [open communication] are essential for [optimizing treatment plans], [managing side effects], and [preventing long-term complications]. This study serves as a testament to the [ongoing progress] in [HIV treatment], offering [hope and optimism] for individuals living with [HIV].

Dr.Camel's Conclusion

This research is like a refreshing oasis in the desert of HIV treatment, offering a simple and effective once-daily regimen for patients. This could potentially make the journey of living with HIV more manageable and comfortable, providing a sense of hope and control for individuals.

Date :
  1. Date Completed 2006-05-18
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

16566083

DOI: Digital Object Identifier

10.1310/1XAE-BB0W-QN5R-AJGJ

Related Literature

Article Analysis
・Side Effects of didanosine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.